Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
editorial
. 1957 Jan 15;76(2):139.

Dextran Sulfate as a Substitute for Heparin

PMCID: PMC1823503  PMID: 20325412

Full text

PDF

Page 139

139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COHEN H., TUDHOPE G. R. Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol. Br Med J. 1956 Nov 3;2(5000):1023–1027. doi: 10.1136/bmj.2.5000.1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DE NICOLA P. Physiopathological classification of the haemorrhagic diseases. Can Med Assoc J. 1952 Dec;67(6):623–629. [PMC free article] [PubMed] [Google Scholar]
  3. FROMMHAGEN L. H., FAHRENBACH M. J., BROCKMAN J. A., Jr, STOKSTAD E. L. R. Heparin-like anticoagulants from Mollusca. Proc Soc Exp Biol Med. 1953 Feb;82(2):280–283. doi: 10.3181/00379727-82-20092. [DOI] [PubMed] [Google Scholar]
  4. JEAVONS S. M., RICKETTS C. R., WALTON K. W. Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate. Br Med J. 1956 Nov 3;2(5000):1016–1023. doi: 10.1136/bmj.2.5000.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. MACMILLAN R. L., BROWN K. W. Haemorrhage in anticoagulant therapy. Can Med Assoc J. 1953 Sep;69(3):279–283. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES